salivary gland neoplasm: ['Tumors of the SALIVARY GLANDS.']
Endpoint definition
↥Report an error or suggest an improvement for this endpoint codes
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
557745 |
1. Apply sex-specific ruleNone |
557745 |
2. Check conditionsNone |
557745 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters: 2 out of 7 registries used, show all original rules. |
666 |
4. Check minimum number of eventsNone |
666 |
5. Include endpointsNone |
666 |
6. Filter based on genotype QC (FinnGen only) |
594 |
Control definitions (FinnGen only)
Controls for this endpoint are individuals that are not cases.
Extra metadata
- Level in the ICD hierarchy
- 3
- First used in FinnGen datafreeze
- DF2
- Parent code in ICD-10
- D33
- Name in latin
- Neoplasma benignum cerebri supratentoriale
Similar endpoints
↥List of similar endpoints to
Benign neoplasm: Brain, supratentorial
based on the number of shared cases.
Similar with more cases:
- Benign neoplasm of brain and other parts of central nervous system
- Benign neoplasms
- Neoplasms
- Any prescribed medicine buy
- Any event in hilmo or specialist outpatient
Similar with less cases:
None
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | |||
| Whole population | 4145 | 2224 | 1899 |
| Only index persons | 3782 | 2059 | 1723 |
| Unadjusted period prevalence (%) | |||
| Whole population | 0.06 | 0.06 | 0.05 |
| Only index persons | 0.07 | 0.08 | 0.07 |
| Median age at first event (years) | |||
| Whole population | 49.48 | 51.35 | 47.25 |
| Only index persons | 48.74 | 50.53 | 46.61 |
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 594 | 344 | 250 |
| Unadjusted period prevalence (%) | 0.12 | 0.12 | 0.11 |
| Median age at first event (years) | 50.59 | 47.10 | 55.38 |
-FinRegistry-
Age distribution of first events
-FinnGen-
Age distribution of first events
-FinRegistry-
Year distribution of first events
-FinnGen-
Year distribution of first events
-FinRegistry-
Cumulative Incidence Function
-FinnGen-
Cumulative Incidence Function
CodeWAS
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 612
- Matched controls
- 6120
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
AA1CG
NOMESCO Finland
Extensive MRI examination of brain with high intensity magnet
22.3
307.7
329
303
AAB00
NOMESCO Finland
Extirpation of intracranial lesion
143.6
307.7
238
27
D33.00
ICD-10 Finland
Medial pilosytic astrocytoma of the cerebrum
+∞
218.2
196
*
AAB10
NOMESCO Finland
Partial excision of intracranial lesion
79.5
206.1
111
17
111
Kela drug reimbursment
Epilepsy and comparable convulsive disorders
14.4
159.7
163
150
D33.07
ICD-10 Finland
Colloid coast in cerebral ventricle
+∞
158.4
145
*
D32.00
ICD-10 Finland
Benign tumor of the meninges on the outer surface of the cerebrum
50.7
155.4
91
21
AA1DG
NOMESCO Finland
Very extensive MRI examination of brain with high intensity magnet
19.8
143.5
118
73
D33.02
ICD-10 Finland
Another benign medial tumor of the cerebrum
+∞
112.0
104
*
N03AF02
ATC
oxcarbazepine; oral
14.4
111.9
109
91
AA1BG
NOMESCO Finland
Standard MRI examination of brain with high intensity magnet
7.6
105.3
184
329
AA1CM
NOMESCO Finland
Extensive MRI examination of brain with 3 Tesla magnet
21.3
103.0
80
43
N03AX14
ATC
levetiracetam; systemic
15.1
97.6
91
70
182
Kela drug reimbursment
Brivaracetam, eslikarbazepin, gabapentin, lacosamide, levetiracetam, perampanel, pregabalin, tiagabin and zonisamide
16.6
91.2
80
55
9530/0-C70.0
ICD-O-3
Meningioma, NOS, of cerebral meninges
42.2
88.8
54
14
D32.02
ICD-10 Finland
Benign tumor of the meninges at the base of the brain
29.6
87.3
59
22
G40.29
ICD-10 Finland
Localization-related (focal)(partial) symptomatic epilepsy and epileptic syndromes with complex partial seizures
17.5
86.0
73
47
D33.08
ICD-10 Finland
Another benign tumor of the cerebral ventricle
+∞
85.5
80
*
G40.22
ICD-10 Finland
Complex partial epileptic seizure with secondary generalization
17.3
83.3
71
46
D33.05
ICD-10 Finland
Other lateral benign tumor in temporal lobe
+∞
73.4
69
*
ZXC95
NOMESCO Finland
Use of surgical navigator
20.3
69.0
54
29
AA1AD
NOMESCO Finland
CT of head and brain
4.1
63.7
290
1110
D43.0
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Brain, supratentorial
87.7
57.2
63
8
G40.9
ICD-10 Finland
Epilepsy, unspecified
9.0
56.7
74
92
AA1AG
NOMESCO Finland
Short MRI examination of brain with median intensity magnet
15.0
55.1
50
36
G40.20
ICD-10 Finland
Complex partial seizures with only alteration of consciousness
20.0
54.9
43
23
D33.30
ICD-10 Finland
Acoustic neuroma
75.0
54.3
61
9
XA800
NOMESCO Finland
Neuropsychological investigation
6.9
50.7
84
137
AAF05
NOMESCO Finland
Ventriculoperitoneal shunt
20.8
50.6
39
20
XCK00
NOMESCO Finland
Perimetry
6.1
46.2
87
161
D33.0
ICD-10 Finland
Benign neoplasm: Brain, supratentorial
+∞
45.4
43
*
G91.1
ICD-10 Finland
Obstructive hydrocephalus
75.8
43.7
49
7
WX700
NOMESCO Finland
Respiratory and circulatory monitoring
3.8
43.0
169
564
H53.4
ICD-10 Finland
Visual field defects
10.7
42.1
47
47
R56.8
ICD-10 Finland
Other and unspecified convulsions
5.7
42.1
85
168
G40.12
ICD-10 Finland
Simple partial seizures with secondary generalization
15.4
39.4
35
24
N03AG01
ATC
valproic acid; systemic, rectal
4.9
36.1
86
196
AA1CD
NOMESCO Finland
Very extensive CT of head and brain
10.9
31.8
35
34
D33.04
ICD-10 Finland
Temporal lobe
+∞
31.5
30
*
183
Kela drug reimbursment
Lamotrigin and topiramate
12.0
31.1
32
28
H02AB02
ATC
dexamethasone; systemic
3.5
29.5
116
380
N03AB02
ATC
phenytoin; systemic
9.9
29.1
34
36
R51.80
ICD-10 Finland
Headache
2.9
28.2
167
696
D33.03
ICD-10 Finland
Pilosytic lateral astrocytoma of the strobe brain
+∞
27.3
26
*
N03AF01
ATC
carbamazepine; oral, rectal
4.9
27.3
64
143
WX882
NOMESCO Finland
High dependency care
6.9
27.2
43
66
D33.01
ICD-10 Finland
Medial ganglion glioma of the cerebrum
+∞
26.2
25
*
D32.9
ICD-10 Finland
Benign neoplasm: Meninges, unspecified
42.1
26.1
32
8
D33.9
ICD-10 Finland
Benign neoplasm: Central nervous system, unspecified
141.0
25.8
27
*
H02AB09
ATC
hydrocortisone; systemic
6.5
23.9
40
65
Z01.0
ICD-10 Finland
Examination of eyes and vision
2.7
23.8
160
706
N03AX18
ATC
lacosamide; systemic
20.5
23.7
35
18
D32.0
ICD-10 Finland
Benign neoplasm: Cerebral meninges
52.0
21.3
25
5
D33.2
ICD-10 Finland
Benign neoplasm: Brain, unspecified
52.0
21.3
25
5
D32.01
ICD-10 Finland
Benign tumor of meninges on interhemispheric surface
24.4
20.1
28
12
G93.0
ICD-10 Finland
Cerebral cysts
37.1
20.0
25
7
D33.06
ICD-10 Finland
Plexus papilloma of the ventricle of the brain
+∞
19.9
19
*
L01AX03
ATC
temozolomide; systemic
22.5
19.7
28
13
R41.8
ICD-10 Finland
Other and unspecified symptoms and signs involving cognitive functions and awareness
3.1
19.3
88
312
E23.00
ICD-10 Finland
Panhypopituitarism
56.9
19.0
22
*
ZXE20
NOMESCO Finland
More than three and less than five hours
2.8
19.0
112
458
D33.7
ICD-10 Finland
Benign neoplasm: Other specified parts of central nervous system
195.8
18.6
19
*
WX408
NOMESCO Finland
General anesthesy, balanced
2.3
18.4
190
1008
AA1DM
NOMESCO Finland
Very extensive MRI examination of brain with 3 Tesla magnet
15.4
17.3
28
19
Z2445
NOMESCO Finland
Psychologist
3.9
17.0
53
147
D35.2
ICD-10 Finland
Benign neoplasm: Pituitary gland
22.6
17.0
24
11
AA1BD
NOMESCO Finland
Extensive CT of head and brain
5.9
17.0
31
55
AAF25
NOMESCO Finland
Removal of shunt of ventricle of brain
92.6
16.6
18
*
AAF99
NOMESCO Finland
Other shunt operation on ventricle of brain or intracerebral cyst
92.6
16.6
18
*
C71.11
ICD-10 Finland
Malignant tumor of frontal lobe grade II glioma
61.7
15.8
18
*
9530/0-C70.9
ICD-O-3
Meningioma, NOS, of meninges, NOS
164.0
15.5
16
*
N88
ICPC
Epilepsy
16.6
15.3
24
15
Z50.8
ICD-10 Finland
Care involving use of other rehabilitation procedures
3.1
15.3
68
237
R90.8
ICD-10 Finland
Other abnormal findings on diagnostic imaging of central nervous system
12.2
15.2
27
23
9560/0-C72.4
ICD-O-3
Schwannoma, NOS, of acoustic nerve
46.2
15.1
18
*
G40.19
ICD-10 Finland
Localization-related (focal)(partial) symptomatic epilepsy and epileptic syndromes with simple partial seizures
17.0
14.9
23
14
G40.10
ICD-10 Finland
Simple partial seizures
19.0
14.8
22
12
2152
FHL
Extraction, big brain
153.5
14.5
15
*
C71.10
ICD-10 Finland
Malignant tumor in frontal lobe without histology
27.9
14.3
19
7
H53.2
ICD-10 Finland
Diplopia
4.5
14.0
35
82
R29.8
ICD-10 Finland
Other and unspecified symptoms and signs involving the nervous and musculoskeletal systems
2.8
13.9
73
279
C71.20
ICD-10 Finland
Malignant tumor in temporal lobe without histology
54.6
13.9
16
*
C71.90
ICD-10 Finland
Malignant tumor in unspecified localization in the brain without histology
54.6
13.9
16
*
N76
ICPC
Neoplasm nervous system unspecified
76.9
13.6
15
*
9505/1-C71.9
ICD-O-3
Ganglioglioma, NOS, of brain, NOS
+∞
13.6
13
*
ZXD10
NOMESCO Finland
Scheduled procedure
1.9
13.5
240
1527
CK2X4
NOMESCO Finland
Optical coherence tomography (OCT) of ocular fundus
2.7
13.3
77
310
D32.03
ICD-10 Finland
Benign meningioma in ventricles
41.0
13.2
16
*
101
Kela drug reimbursment
Anterior pituitary hypofunction
15.5
13.2
21
14
Z03.3
ICD-10 Finland
Observation for suspected nervous system disorder
3.2
13.0
53
175
H47.2
ICD-10 Finland
Optic atrophy
29.1
13.0
17
6
ZXC40
NOMESCO Finland
Use of ultrasound
13.4
13.0
22
17
D43.9
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Central nervous system, unspecified
51.1
12.9
15
*
C71.29
ICD-10 Finland
Malignant tumor in temporal lobe other or unspecified histology
+∞
12.5
12
*
9421/1-C71.9
ICD-O-3
Pilocytic astrocytoma of brain, NOS
+∞
12.5
12
*
AWB00
NOMESCO Finland
Reoperation for superficial infection in surgery of the nervous system
132.6
12.5
13
*
AAG00
NOMESCO Finland
Stereotactic intracranial biopsy
38.4
12.3
15
*
R42
ICD-10 Finland
Dizziness and giddiness
2.0
12.2
155
872
AAF00
NOMESCO Finland
Ventriculostomy
18.5
12.1
18
10
DE2CG
NOMESCO Finland
Acoustic channel extensive MRI examination with high intensity magnet
10.3
12.1
23
23
G91.0
ICD-10 Finland
Communicating hydrocephalus
21.8
12.1
17
8
N29
ICPC
Neurological sympt/complt other
5.8
12.0
22
39
ZXE10
NOMESCO Finland
More than one and less than three hours
1.9
12.0
223
1428
N05BA09
ATC
clobazam; oral
12.0
11.9
21
18
Z00.4
ICD-10 Finland
General psychiatric examination, not elsewhere classified
2.4
11.8
85
379
TAB00
NOMESCO Finland
Lumbar puncture
3.2
11.8
47
153
AAG50
NOMESCO Finland
Stereotactic intracranial radiotherapy
16.8
11.7
18
11
ZXC86
NOMESCO Finland
Use of endoscopic device
30.7
11.7
15
5
CBK11
NOMESCO Finland
Operation for lagophtalmus with implant
+∞
11.5
11
*
D33.37
ICD-10 Finland
Another benign tumor of the cranial nerves
+∞
11.5
11
*
D33.3
ICD-10 Finland
Benign neoplasm: Cranial nerves
+∞
11.5
11
*
ABB00
NOMESCO Finland
Excision of lesion of spinal canal
122.2
11.5
12
*
Z3226
NOMESCO Finland
Physiotherapist
2.1
11.4
125
665
Z3229
NOMESCO Finland
Other healthcare associate professional
2.7
11.0
64
258
R4150
NOMESCO Finland
Neuropsychological rehabilitation
9.8
10.8
21
22
G91.9
ICD-10 Finland
Hydrocephalus, unspecified
21.9
10.7
15
7
AA4CG
NOMESCO Finland
Extensive MRI examination of sella turcica with high intensity magnet
10.3
10.6
20
20
N75
ICPC
Benign neoplasm nervous system
111.9
10.4
11
*
D33.39
ICD-10 Finland
Benign tumor of the cranial nerves UNS
111.9
10.4
11
*
C71.21
ICD-10 Finland
Malignant tumor of temporal lobe grade II glioma
111.9
10.4
11
*
D43.1
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Brain, infratentorial
111.9
10.4
11
*
C71.50
ICD-10 Finland
Malignant tumor of cerebral ventricle without histology
+∞
10.4
10
*
D33.10
ICD-10 Finland
Benign pilosytic astrocytoma of brain stem
+∞
10.4
10
*
2250A
ICD-9 Finland
Benign neoplasm of brain and other parts of nervous system, Brain
+∞
10.4
10
*
H02.2
ICD-10 Finland
Lagophthalmos
33.1
10.4
13
*
CS424
NOMESCO Finland
Visual field testing with Goldmann perimetry
9.8
10.3
20
21
G40.21
ICD-10 Finland
Partial epileptic seizure with cloudiness and automatism
19.2
10.3
15
8
AA1BM
NOMESCO Finland
MRI examination of brain with 3 Tesla magnet
7.7
10.3
23
31
R51
ICD-10 Finland
Headache
2.9
10.2
48
173
130
Kela drug reimbursment
Malignant tumour
2.6
10.0
61
251
C71.00
ICD-10 Finland
Malignant tumor of the cerebrum except lobes and ventricles without histology
40.8
10.0
12
*
GD1UA
NOMESCO Finland
Thorax X-ray examination outside radiological department
2.1
9.9
108
572
N06CA01
ATC
amitriptyline and psycholeptics; systemic
2.4
9.9
70
310
H49.0
ICD-10 Finland
Third [oculomotor] nerve palsy
26.5
9.8
13
5
R4110
NOMESCO Finland
Physiotherapy
1.8
9.8
176
1103
N03AX09
ATC
lamotrigine; oral
2.9
9.7
46
166
G40.2
ICD-10 Finland
Localization-related (focal)(partial) symptomatic epilepsy and epileptic syndromes with complex partial seizures
11.6
9.6
17
15
D32.04
ICD-10 Finland
Secondary or multiple benign tumor of the meninges above the exam
30.5
9.4
12
*
D43.2
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Brain, unspecified
30.5
9.4
12
*
9413/0-C71.9
ICD-O-3
Dysembryoplastic neuroepithelial tumor of brain, NOS
+∞
9.4
9
*
2252A
ICD-9 Finland
Benign neoplasm of brain and other parts of nervous system, Cerebral meninges
+∞
9.4
9
*
Z3231
NOMESCO Finland
Registered nurse
1.8
9.2
175
1113
G40
ICD-10 Finland
Epilepsy
7.9
9.2
20
26
WF099
NOMESCO Finland
Other radiotherapy
15.9
9.1
14
9
GD1QA
NOMESCO Finland
Supine thorax X-ray examination
2.0
9.1
106
575
C71.12
ICD-10 Finland
Malignant tumor of frontal lobe grade III glioma
37.3
9.0
11
*
Q28.3
ICD-10 Finland
Other malformations of cerebral vessels
24.4
8.9
12
5
CS444
NOMESCO Finland
Visual field testing with Octopus automated perimetry
3.4
8.9
32
98
AAF20
NOMESCO Finland
Revision of shunt of ventricle of brain
20.4
8.5
12
6
G41.9
ICD-10 Finland
Status epilepticus, unspecified
20.4
8.5
12
6
ZXE30
NOMESCO Finland
More than five and less than seven hours
3.1
8.5
36
122
WF002
NOMESCO Finland
Radical radiotherapy
2.8
8.4
42
156
R1230
NOMESCO Finland
Neuropsychological evaluation of need and possibilities to rehabilitation
6.9
8.4
20
30
WX404
NOMESCO Finland
Intravenous generell anesthesy
1.9
8.4
129
766
D33.11
ICD-10 Finland
Brain stem
+∞
8.3
8
*
AAJ20
NOMESCO Finland
Excision of epileptic focus
+∞
8.3
8
*
H01AC01
ATC
somatropin; parenteral
14.7
8.2
13
9
H90.3
ICD-10 Finland
Sensorineural hearing loss, bilateral
2.0
8.1
104
581
G40.09
ICD-10 Finland
Other or unspecified partial (focal) idiopathic epilepsy or epileptic syndrome with local onset
17.5
8.1
12
7
CS434
NOMESCO Finland
Visual field testing with Humphrey automated perimetry
4.2
8.1
21
51
G51.0
ICD-10 Finland
Bell palsy
3.9
8.0
23
60
XKD00
NOMESCO Finland
Uroflowmetry
2.1
8.0
85
445
G40.11
ICD-10 Finland
Simple partial epileptic seizure that develops into a complex partial seizure
13.2
7.9
13
10
H49.2
ICD-10 Finland
Sixth [abducent] nerve palsy
11.0
7.8
14
13
F32.9
ICD-10 Finland
Depressive episode, unspecified
2.0
7.7
92
501
XCW99
NOMESCO Finland
Other investigative procedure of eye
2.2
7.5
69
341
D32.05
ICD-10 Finland
Cerebral meninges
81.0
7.4
8
*
E22.80
ICD-10 Finland
Central precocious puberty
81.0
7.4
8
*
YA1AD
NOMESCO Finland
CT examination of head and neck for dose design of radiotherapy
9.5
7.3
14
15
D42.0
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Cerebral meninges
+∞
7.3
7
*
9505/1-C71.2
ICD-O-3
Ganglioglioma, NOS, of temporal lobe
+∞
7.3
7
*
D32.06
ICD-10 Finland
Benign tumor of the meninges os petrosum or clivus area
+∞
7.3
7
*
D32.1
ICD-10 Finland
Benign neoplasm: Spinal meninges
+∞
7.3
7
*
AAA10
NOMESCO Finland
Biopsy through craniotomy
+∞
7.3
7
*
Q85.01
ICD-10 Finland
Neurofibromatosis, type 2
+∞
7.3
7
*
N03AX23
ATC
brivaracetam; systemic
16.0
7.2
11
7
N05AX08
ATC
risperidone; systemic
2.2
7.2
61
291
301
Kela drug reimbursment
Growth hormone
30.4
7.2
9
*
D32.07
ICD-10 Finland
Secondary or multiple benign tumor of the meninges below the exam
30.4
7.2
9
*
CS494
NOMESCO Finland
Other visual field testing
3.6
7.1
23
66
WX872
NOMESCO Finland
Intensive care
2.8
6.9
33
120
N03AX11
ATC
topiramate; oral
3.3
6.9
25
77
D35.30
ICD-10 Finland
Craniopharyngoma
40.5
6.8
8
*
WX110
NOMESCO Finland
Infiltration anesthesia
1.6
6.8
439
3726
A02BC02
ATC
pantoprazole; systemic
1.6
6.7
394
3264
CS5Z4
NOMESCO Finland
Specialised imaging for glaucoma
4.1
6.7
18
45
Z01.8
ICD-10 Finland
Other specified special examinations
1.7
6.6
137
883
D18.0
ICD-10 Finland
Haemangioma, any site
3.7
6.6
21
59
G40.39
ICD-10 Finland
Other or unspecified generalized epileptic syndromes with atonic, clonic, myoclonic or tonic-clonic seizures
12.4
6.6
11
9
GD1AA
NOMESCO Finland
Thorax X-ray examination
1.5
6.5
273
2093
T85.0
ICD-10 Finland
Mechanical complication of ventricular intracranial (communicating) shunt
70.6
6.4
7
*
ZZC00
NOMESCO Finland
Graft of fascia
70.6
6.4
7
*
D33.40
ICD-10 Finland
Benign glioma of the spinal cord (grade I)
70.6
6.4
7
*
ZYC01
NOMESCO Finland
Remote contact by phone
2.3
6.3
46
206
E22.1
ICD-10 Finland
Hyperprolactinaemia
18.2
6.3
9
5
102
Kela drug reimbursment
Diabetes insipidus
18.2
6.3
9
5
G40.1
ICD-10 Finland
Localization-related (focal)(partial) symptomatic epilepsy and epileptic syndromes with simple partial seizures
18.2
6.3
9
5
N03AX15
ATC
zonisamide; oral
18.2
6.3
9
5
2159
FHL
Other measure in this category
+∞
6.3
6
*
C71.59
ICD-10 Finland
Malignant tumor of cerebral ventricle other or unspecified histology
+∞
6.3
6
*
D35.59
ICD-10 Finland
Other paragangliom
+∞
6.3
6
*
AAE32
NOMESCO Finland
Translabyrinthine excision acoustic neurinome
+∞
6.3
6
*
C710, 8000, 0
ICD-O-3
+∞
6.3
6
*
C71.22
ICD-10 Finland
Malignant tumor of temporal lobe grade III glioma
+∞
6.3
6
*
D44.5
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Pineal gland
+∞
6.3
6
*
2251A
ICD-9 Finland
Benign neoplasm of brain and other parts of nervous system, Cranial nerves
+∞
6.3
6
*
C71.40
ICD-10 Finland
Malignant tumor of the occipital lobe without histology
+∞
6.3
6
*
AA7AA
NOMESCO Finland
Liquor cerebri shunt X-ray examinatin without contrast
27.0
6.2
8
*
YA1VG
NOMESCO Finland
MRI examination of head and neck with high intesity magnet for dose design of radiotherapy
12.7
6.1
10
8
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
cases
controls
unit
-log10(p)
N cases
N controls
48
39
13.27
49.23
1.3
1.6
—
—
—
0
0
167
570
3.65
40.87
7.1
9.2
1.09
0.99
mmol/l
0.15
128
483
167
582
3.57
39.45
7.1
9.0
5.06
5.14
kpa
0.58
159
563
167
582
3.57
39.45
7.1
9.0
15.80
12.50
kpa
6.90
158
566
44
50
9.40
35.84
2.5
1.2
—
—
—
0
0
61
128
5.18
27.99
2.3
1.7
2488.14
134.36
e6/l
0.80
49
100
60
126
5.17
27.50
2.2
1.7
15.32
16.33
e6/l
0.03
47
96
389
2585
2.39
23.19
8.7
7.4
1.20
1.21
mmol/l
1.73
365
2236
361
2326
2.35
23.09
8.2
6.8
1.20
1.21
mmol/l
3.97
345
2150
56
130
4.64
22.74
2.0
1.6
3.53
3.66
mmol/l
0.33
51
122
427
3124
2.21
17.88
6.7
5.3
6.35
6.61
mmol/l
2.43
413
2939
260
1593
2.10
17.26
3.0
2.1
321.56
225.45
u/l
0.39
251
1512
120
558
2.43
15.44
3.5
1.9
312.55
379.39
nmol/l
3.10
110
519
27
25
11.24
14.62
1.8
1.3
—
—
—
0
0
213
1304
1.97
13.42
2.4
2.3
—
—
—
0
0
116
564
2.30
13.37
7.0
6.5
—
—
—
0
0
217
1339
1.96
13.35
4.1
4.1
93.45
90.95
%
0.94
211
1322
33
77
4.47
13.28
5.1
5.5
374.71
380.48
umol/l
0.07
28
69
26
56
4.80
11.51
1.1
1.1
—
—
—
0
0
338
2484
1.81
11.45
2.8
2.8
—
—
estimate
—
0
0
141
789
2.02
11.21
2.3
2.1
28.60
29.49
s
0.65
141
773
26
58
4.64
11.05
1.1
1.1
—
—
—
0
0
22
49
4.62
9.37
1.1
1.1
—
—
—
0
0
21
33
6.55
8.55
1.1
1.0
—
—
—
0
0
86
458
2.02
7.69
6.0
7.5
8.58
9.31
mmol/l
0.39
81
438
294
2245
1.60
7.38
5.2
5.0
35.80
36.14
g/l
0.47
280
2119
138
872
1.75
7.23
1.9
2.0
—
—
—
0
0
18
31
5.95
6.96
1.1
1.1
1.35
1.12
u/l
0.26
12
16
46
199
2.42
6.84
2.7
1.4
7.71
9.18
u/l
0.31
37
150
104
614
1.84
6.82
1.8
2.0
—
—
—
0
0
10
6
16.92
6.76
1.4
1.2
—
—
—
0
0
477
4135
1.70
6.76
5.4
4.3
14.48
14.66
pmol/l
0.85
448
3772
379
3109
1.58
6.72
11.3
10.0
4.24
4.07
e9/l
0.64
323
2715
303
2366
1.56
6.67
11.2
12.3
1.18
1.21
inr
0.36
263
1954
106
643
1.78
6.34
1.8
1.9
—
—
—
0
0
17
31
5.61
6.34
1.1
1.2
0.59
0.50
ratio
—
10
16
342
2778
1.52
6.06
7.3
6.5
9.97
11.67
umol/l
3.44
324
2653
459
3998
1.59
5.75
9.3
8.0
77.95
79.65
u/l
0.40
441
3791
(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
15
33
4.63
4.89
1.1
1.1
—
—
—
0
0
248
1951
1.46
4.77
3.8
3.7
34.44
64.94
ng/l
0.49
173
1332
66
381
1.82
4.64
2.5
2.4
8.97
15.42
au/ml
—
6
36
126
867
1.57
4.60
3.8
3.7
0.83
0.82
mmol/l
0.77
121
822
347
2919
1.44
4.59
4.7
3.7
0.00
0.54
estimate
0.51
54
565
296
2421
1.43
4.56
2.6
2.5
74.26
75.19
nmol/l
0.27
273
2189
19
66
2.94
4.37
2.1
1.3
0.67
0.53
nmol/l
0.52
19
60
562
5250
1.86
4.36
20.5
14.8
24.45
22.97
mg/l
0.51
498
4281
12
24
5.08
4.33
1.5
1.0
—
—
—
0
0
444
3936
1.47
4.25
5.1
4.3
10.09
11.08
mm/h
0.92
419
3672
12
25
4.87
4.20
1.3
1.2
—
—
—
0
0
55
310
1.85
4.18
1.9
1.7
—
—
—
0
0
340
2886
1.40
4.06
4.7
3.7
0.00
5.17
estimate
0.80
58
606
338
2868
1.40
4.03
4.7
3.6
0.00
0.00
estimate
-0.00
55
600
225
1786
1.41
3.95
3.3
3.4
2.35
2.36
mmol/l
0.84
199
1635
13
32
4.13
3.92
1.0
1.1
—
—
—
0
0
9
15
6.07
3.82
1.1
1.3
—
—
—
0
0
397
3479
1.40
3.82
5.6
4.4
207.20
1159.96
e6/l
—
5
56
31
147
2.17
3.81
1.2
1.2
—
—
—
0
0
36
182
2.04
3.76
1.4
1.4
—
—
—
0
0
102
701
1.55
3.71
6.5
6.1
1.06
1.04
mmol/l
0.22
89
650
526
4885
1.55
3.47
6.2
5.3
1.96
1.88
mu/l
0.21
495
4522
201
1600
1.38
3.37
5.0
3.8
0.00
0.01
estimate
1.15
53
570
79
524
1.58
3.36
4.9
4.4
1.69
1.58
mmol/l
0.12
73
449
34
177
1.98
3.31
1.7
1.5
0.07
0.05
iu/ml
—
9
29
6
7
8.64
3.27
1.3
1.1
2.35
7.54
nmol/l
—
6
7
51
304
1.74
3.26
2.6
1.4
24.02
23.14
iu/l
0.06
43
248
165
1279
1.40
3.22
5.1
3.7
1.02
1.02
kg/l
0.23
119
845
134
1003
1.43
3.19
2.8
2.7
2.42
2.44
mmol/l
1.78
120
904
58
363
1.66
3.12
1.8
1.5
—
—
—
0
0
8
16
5.05
3.06
1.0
1.1
—
—
—
0
0
8
16
5.05
3.06
1.9
2.3
26.89
19.06
umol/l
—
8
16
8
16
5.05
3.06
1.0
1.3
—
—
—
0
0
8
16
5.05
3.06
1.0
1.1
—
—
—
0
0
8
16
5.05
3.06
1.0
1.2
—
—
—
0
0
8
16
5.05
3.06
1.0
1.1
—
—
—
0
0
156
1209
1.39
3.03
2.9
2.6
4.38
5.90
e6/l
0.73
144
1099
34
185
1.89
2.93
1.6
1.8
—
—
—
0
0
6
10
6.05
2.70
1.0
1.3
—
—
—
0
0
40
236
1.74
2.69
1.8
2.2
37.97
39.66
u/l
0.21
35
215
5
7
7.19
2.55
1.0
1.6
—
—
—
0
0
59
391
1.56
2.55
3.3
2.4
6.73
6.57
ug/l
0.03
52
352
201
1661
1.31
2.51
3.0
2.5
60.86
61.74
u/l
0.06
184
1551
7
16
4.41
2.48
1.0
1.2
—
—
—
0
0
67
460
1.51
2.48
3.0
2.4
12.67
13.13
nmol/l
0.16
62
423
108
813
1.40
2.47
1.9
1.7
1122.37
1180.02
nmol/l
0.31
87
620
46
290
1.63
2.44
3.9
3.6
0.70
0.61
%
0.59
46
290
11
38
2.93
2.42
1.5
1.8
—
—
—
0
0
262
2252
1.29
2.41
2.3
2.0
94.23
95.97
pmol/l
0.24
135
1193
119
918
1.37
2.35
4.0
2.9
1.29
0.92
e6/l
0.49
69
481
572
5497
1.62
2.31
14.6
11.6
26.76
26.47
u/l
0.13
560
5357
8
23
3.51
2.27
1.0
1.0
—
—
—
0
0
28
157
1.82
2.25
1.1
1.3
—
—
—
0
0
5
9
5.59
2.21
1.0
1.3
—
—
—
0
0
401
3657
1.28
2.21
4.3
3.3
51.30
43.23
u/l
1.15
388
3476
524
4959
1.39
2.20
18.2
14.4
86.22
84.23
ml/min/173m2
1.17
483
4552
179
1481
1.29
2.18
1.8
1.6
20.93
20.27
nmol/l
0.18
155
1254
64
449
1.48
2.15
2.0
2.4
0.30
0.25
e6/l
0.27
64
429
32
190
1.72
2.14
2.7
1.8
1.60
3.22
ug/l
0.45
25
166
207
1749
1.28
2.13
4.1
3.3
34.56
82.22
e6/l
0.62
168
1339
33
199
1.70
2.10
1.7
1.9
—
—
—
0
0
16
76
2.13
2.04
1.0
1.4
—
—
—
0
0
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
23
126
1.86
2.01
2.3
2.9
0.39
0.35
iu/ml
—
9
68
18
92
1.99
1.92
1.3
1.2
4.27
3.90
u/ml
0.06
11
42
21
114
1.87
1.89
2.0
1.4
0.23
0.33
nmol/l
0.69
14
89
8
28
2.88
1.86
1.1
1.8
—
—
—
0
0
8
28
2.88
1.86
1.1
1.8
—
—
—
0
0
169
1417
1.27
1.82
2.9
2.2
2.59
2.81
mg/l
0.77
145
1230
9
36
2.52
1.74
1.0
1.3
—
—
—
0
0
80
610
1.36
1.72
5.0
4.7
31.54
32.06
%
0.19
61
393
8
31
2.60
1.66
1.1
1.1
1.08
1.05
ratio
—
8
26
216
1883
1.23
1.62
3.8
3.2
28.49
32.50
u/l
1.35
200
1797
17
91
1.89
1.62
1.3
1.2
1.20
4.07
u/ml
—
5
30
27
167
1.65
1.61
1.9
3.0
171.56
186.88
%
0.48
27
162
15
77
1.97
1.60
1.5
1.6
—
—
—
0
0
14
70
2.02
1.60
1.4
1.7
—
—
—
0
0
25
152
1.67
1.59
1.4
1.7
—
—
—
0
0
157
1325
1.25
1.59
2.6
2.9
329.65
342.45
umol/l
0.84
142
1182
13
64
2.05
1.55
1.1
1.2
—
—
—
0
0
8
33
2.44
1.54
1.3
1.7
—
—
—
0
0
106
857
1.29
1.53
4.0
3.0
2.04
2.43
e6/l
0.25
56
422
175
1502
1.23
1.51
4.2
3.1
0.33
0.33
e6/l
0.02
134
1100
45
623
0.70
1.51
1.7
1.9
3.40
3.44
ratio
0.06
30
477
18
101
1.81
1.50
1.4
1.7
—
—
—
0
0
9
38
2.39
1.46
4.3
2.9
—
—
—
0
0
11
213
0.51
1.44
1.1
1.1
1.45
1.54
g/l
0.98
11
213
7
29
2.43
1.39
1.0
1.0
1556.74
1485.59
miu/ml
—
7
29
7
29
2.43
1.39
1.3
1.7
—
—
—
0
0
40
282
1.45
1.37
1.5
1.4
—
—
—
0
0
6
23
2.62
1.37
1.3
1.1
—
—
—
0
0
46
334
1.41
1.35
3.4
3.9
0.74
1.70
mmol/l
1.08
35
241
55
412
1.37
1.35
1.7
2.1
—
—
—
0
0
119
993
1.25
1.33
4.0
3.8
95.94
298.06
ng/l
2.34
87
726
12
219
0.54
1.32
1.4
1.1
0.86
0.89
g/l
0.17
12
219
6
24
2.51
1.30
1.0
1.3
11.17
18.05
u/l
—
6
19
586
5733
1.52
1.29
32.1
22.6
4.49
4.52
e12/l
0.86
580
5622
51
381
1.37
1.28
4.7
4.0
87.00
77.63
ng/l
0.28
40
338
9
44
2.06
1.27
1.8
2.5
—
—
—
0
0
293
2677
1.18
1.26
3.5
3.0
107.39
105.52
ug/l
0.07
273
2518
33
466
0.69
1.26
1.4
1.7
3.13
3.40
mmol/l
0.67
17
322
6
25
2.41
1.24
1.0
1.3
57.33
78.35
u/l
—
6
20
15
85
1.78
1.24
1.1
1.1
—
—
—
0
0
36
255
1.44
1.23
1.7
2.0
3.55
8.30
iu/ml
—
8
64
11
56
1.98
1.22
1.3
1.2
—
79.00
—
0
6
10
49
2.06
1.22
1.0
1.3
97.50
59.02
u/l
—
10
43
21
133
1.60
1.19
3.0
3.2
0.27
2.13
index
2.97
11
78
63
493
1.31
1.18
2.0
2.2
—
—
—
0
0
105
876
1.24
1.18
3.0
2.4
13.20
13.38
umol/l
0.09
95
821
24
158
1.54
1.16
1.4
1.7
—
—
—
0
0
7
30
2.35
1.12
1.3
1.7
—
—
—
0
0
10
51
1.98
1.11
6.1
3.4
1.61
6.50
nmol/l
—
10
51
63
498
1.30
1.11
3.3
2.6
0.22
0.22
g/l
0.35
57
470
167
1470
1.19
1.09
3.1
3.3
829.14
1142.50
ng/l
1.35
146
1251
141
1227
1.19
1.05
1.9
1.8
1.60
1.26
mg/l
0.55
110
950
123
1063
1.20
0.99
1.3
1.3
35.21
30.79
iu/ml
0.09
30
327
9
49
1.85
0.99
1.0
1.2
—
—
—
0
0
9
49
1.85
0.99
1.0
1.2
—
—
—
0
0
52
409
1.30
0.97
2.4
2.7
68.44
69.04
ml/min/173m2
0.03
16
176
242
2216
1.15
0.95
4.9
3.5
0.00
0.02
estimate
1.22
47
504
9
51
1.78
0.95
1.0
1.2
—
—
—
0
0
9
51
1.78
0.95
1.0
1.2
—
—
—
0
0
33
246
1.36
0.89
4.4
3.3
1.02
1.02
ratio
0.11
25
232
89
756
1.21
0.87
3.1
2.4
20.84
22.90
%
0.87
81
713
50
398
1.28
0.87
2.0
3.0
67.54
66.92
g/l
0.25
44
368
148
1654
0.86
0.85
3.8
3.0
0.00
0.06
estimate
0.60
47
488
6
31
1.94
0.84
1.0
1.1
—
—
—
0
0
18
121
1.50
0.83
1.2
1.7
—
—
—
0
0
14
89
1.59
0.82
1.3
1.7
—
—
—
0
0
19
132
1.45
0.76
1.2
1.6
—
—
—
0
0
21
150
1.41
0.74
1.5
1.2
—
—
—
0
0
9
55
1.65
0.73
1.0
1.1
—
—
—
0
0
11
68
1.63
0.72
1.3
1.6
—
—
—
0
0
27
203
1.35
0.72
1.9
1.3
—
—
—
0
0
21
152
1.40
0.70
1.1
1.2
0.97
3.00
u/ml
1.20
15
86
116
1030
1.16
0.70
1.6
1.7
437.59
19217929.75
pmol/l
0.72
101
869
16
110
1.47
0.69
1.1
1.6
—
—
—
0
0
7
42
1.67
0.68
5.1
2.7
1099.71
853.93
mg
—
7
42
7
117
0.59
0.68
1.0
1.5
—
—
—
0
0
14
94
1.50
0.67
1.0
1.1
0.04
0.14
u/ml
—
7
30
5
29
1.73
0.64
1.6
1.8
3.40
7.72
nmol/l
—
5
24
8
49
1.64
0.62
11.6
3.4
31.51
50.97
u/ml
—
8
49
10
63
1.60
0.62
1.3
1.7
—
—
—
0
0
16
113
1.43
0.61
1.3
1.6
—
—
—
0
0
33
263
1.27
0.61
1.8
2.3
7770.88
5550.35
u/l
—
6
111
110
984
1.14
0.60
1.3
1.3
4.51
11.04
u/ml
1.32
45
379
15
209
0.71
0.60
1.9
1.6
—
—
—
0
0
375
3598
1.11
0.60
3.2
3.3
—
—
—
0
0
81
709
1.16
0.60
1.9
1.8
1.55
1.45
%
0.50
73
625
21
157
1.35
0.60
1.1
1.1
—
4.42
—
0
21
0
23
0.00
0.58
0.0
1.0
—
41.04
—
0
23
6
37
1.63
0.55
1.7
1.6
—
—
—
0
0
16
116
1.39
0.55
1.3
2.1
140.50
128.92
g/l
—
10
91
50
424
1.20
0.54
1.2
1.3
182.34
168.03
u/ml
0.08
20
184
16
214
0.74
0.52
1.3
1.9
—
—
—
0
0
49
418
1.19
0.50
1.7
1.4
—
—
—
0
0
92
827
1.13
0.49
3.0
2.4
2.37
2.34
g/l
0.22
82
766
28
226
1.25
0.49
1.4
1.4
195.45
244.64
miu/ml
0.24
11
112
8
120
0.66
0.46
1.5
1.5
51.73
53.15
ug/l
—
8
120
39
330
1.19
0.45
2.8
3.2
243.76
178.37
ng/l
0.27
33
293
12
162
0.74
0.43
1.3
1.6
—
—
—
0
0
10
70
1.44
0.42
1.1
1.3
—
—
—
0
0
5
33
1.52
0.41
4.0
3.1
0.80
0.82
index
—
5
33
0
16
0.00
0.41
0.0
1.5
—
—
—
0
0
10
138
0.72
0.41
1.2
1.8
—
—
—
0
0
0
18
0.00
0.40
0.0
1.1
—
2.23
—
0
11
0
18
0.00
0.40
0.0
1.3
—
—
—
0
0
0
19
0.00
0.39
0.0
1.0
—
0.46
—
0
19
503
4941
1.10
0.38
5.5
4.9
5.74
5.89
mmol/l
2.30
465
4553
9
67
1.35
0.38
1.9
1.4
—
—
—
0
0
9
67
1.35
0.38
1.1
1.3
—
—
—
0
0
9
68
1.33
0.37
1.1
1.3
—
—
—
0
0
9
68
1.33
0.37
1.1
1.3
—
—
—
0
0
10
72
1.40
0.37
1.1
1.3
—
—
—
0
0
10
72
1.40
0.37
1.1
1.3
—
—
—
0
0
6
44
1.37
0.34
1.2
1.2
91.33
105.20
pmol/l
—
6
44
6
46
1.31
0.33
1.0
1.1
—
—
—
0
0
18
146
1.24
0.32
1.2
1.2
—
10.50
—
0
8
6
47
1.28
0.32
1.0
1.0
—
—
—
0
0
57
516
1.12
0.30
3.6
2.4
45.74
31.12
u/l
0.72
47
429
156
1480
1.07
0.30
5.5
5.4
3.84
2.43
ug/l
0.55
141
1332
125
1177
1.08
0.29
5.0
4.5
22.64
21.53
%
0.44
71
537
7
56
1.25
0.29
1.3
1.5
—
—
—
0
0
7
56
1.25
0.29
1.3
1.5
—
—
—
0
0
7
56
1.25
0.29
1.3
1.5
—
—
—
0
0
19
158
1.21
0.28
1.5
1.4
267.33
315.13
ug/g
—
9
89
8
65
1.23
0.27
1.0
1.3
—
—
—
0
0
53
483
1.11
0.26
3.3
4.5
46.93
31.64
ug/l
0.13
42
390
19
160
1.19
0.25
1.8
1.6
—
—
—
0
0
15
181
0.82
0.25
1.3
1.5
—
—
—
0
0
84
784
1.08
0.25
1.9
2.2
—
—
—
0
0
23
198
1.17
0.25
8.8
5.0
1.28
1.39
mg/l
0.47
23
178
90
844
1.08
0.24
2.0
2.3
—
—
—
0
0
228
2206
1.05
0.23
1.9
2.0
1.50
1.36
mmol/l
1.09
196
1877
17
143
1.19
0.23
1.1
1.3
—
—
—
0
0
18
211
0.85
0.23
1.4
1.8
2.24
3.33
mg/l
—
10
163
189
1821
1.05
0.23
4.6
3.4
7.33
7.87
mmol/l
0.93
170
1562
21
181
1.17
0.23
1.3
1.3
—
—
—
0
0
5
41
1.22
0.22
1.2
1.2
2387.20
216931.72
e6/l
—
5
29
12
98
1.23
0.21
2.1
1.8
—
—
—
0
0
5
43
1.16
0.21
1.4
2.0
—
—
—
0
0
0
13
0.00
0.21
0.0
1.4
—
8.39
—
0
8
14
118
1.19
0.19
2.1
1.6
—
—
—
0
0
21
185
1.14
0.18
1.3
1.5
—
—
—
0
0
18
157
1.15
0.17
2.3
2.1
3.70
4.96
iu/l
—
9
59
16
184
0.87
0.17
1.3
1.5
0.89
0.94
ratio
—
8
117
16
184
0.87
0.17
1.3
1.5
1.56
1.16
ratio
—
8
117
16
184
0.87
0.17
1.3
1.5
1.61
1.22
ratio
—
8
117
7
63
1.11
0.17
1.0
1.2
—
—
—
0
0
15
172
0.87
0.16
2.6
2.7
—
—
—
0
0
6
76
0.79
0.15
1.0
1.4
6.93
7.15
mmol/l
—
6
62
48
512
0.93
0.15
4.1
3.3
—
—
—
0
0
9
83
1.09
0.14
1.4
1.4
—
—
—
0
0
29
266
1.09
0.14
1.4
1.5
0.34
0.29
mg/l
—
10
112
20
180
1.11
0.13
1.2
1.2
—
2.63
—
0
18
65
621
1.05
0.12
3.1
2.9
7.70
7.96
umol/l
0.04
53
558
21
191
1.10
0.12
2.1
1.9
37.62
39.56
nmol/l
0.16
21
183
11
95
1.16
0.11
1.2
1.3
—
—
—
0
0
11
95
1.16
0.11
1.2
1.3
—
—
—
0
0
506
5094
0.96
0.11
5.2
5.0
4.67
4.63
mmol/l
0.32
482
4776
16
143
1.12
0.11
2.3
4.1
1.29
2.74
ratio
1.28
11
78
170
1661
1.03
0.11
4.3
4.2
7.81
9.28
mg/mmol
0.20
114
1055
17
153
1.11
0.11
1.2
1.1
—
—
—
0
0
30
321
0.93
0.10
1.0
1.0
—
—
—
0
0
14
156
0.90
0.10
1.1
1.1
—
10.53
—
0
19
12
106
1.13
0.10
2.8
4.0
20.83
28.99
mg/l
—
6
72
15
135
1.11
0.09
1.3
1.2
—
—
—
0
0
479
4821
0.97
0.09
6.5
6.2
37.91
38.97
mmol/mol
2.48
449
4535
17
155
1.10
0.09
1.2
1.1
—
—
—
0
0
5
65
0.77
0.08
3.6
2.4
1.17
1.19
mmol/l
—
5
65
5
65
0.77
0.08
3.6
2.4
105.60
105.72
mmol/l
—
5
65
123
1205
1.03
0.07
1.5
1.6
—
—
—
0
0
505
5073
0.97
0.07
5.1
4.8
1.48
1.46
mmol/l
0.36
477
4729
10
90
1.11
0.05
1.1
1.3
—
—
—
0
0
445
4471
0.98
0.05
25.0
18.6
13.57
13.52
%
0.29
445
4430
24
229
1.05
0.04
1.4
1.5
—
—
—
0
0
30
290
1.04
0.03
1.3
1.3
—
—
—
0
0
89
902
0.98
0.03
1.3
1.5
—
—
—
0
0
14
132
1.06
0.02
1.0
1.1
0.22
1.74
u/ml
—
9
71
486
4848
1.01
0.02
4.3
4.1
1.25
1.28
mmol/l
0.37
455
4489
144
1430
1.01
0.01
1.4
1.3
0.96
2.08
u/ml
1.18
35
383
515
5157
0.99
0.01
5.9
5.6
2.74
2.72
mmol/l
0.18
487
4822
10
95
1.05
0.00
1.1
1.1
—
1.70
—
0
16
20
204
0.98
0.00
3.1
3.4
190.48
1796.91
u/ml
1.13
20
175
88
879
1.00
0.00
3.1
3.1
0.83
0.76
ug/l
0.26
58
537
0
8
0.00
0.00
0.0
1.1
—
—
—
0
0
6
68
0.88
-0.00
1.0
1.0
—
—
—
0
0
0
6
0.00
-0.00
0.0
2.7
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.8
—
—
—
0
0
0
6
0.00
-0.00
0.0
1.5
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.0
—
52.40
—
0
5
0
6
0.00
-0.00
0.0
1.2
—
0.67
—
0
6
0
7
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
9
0.00
-0.00
0.0
1.7
—
1.21
—
0
9
11
110
1.00
-0.00
2.6
3.3
12.02
7.93
pmol/l
0.70
11
110
Mortality – FinRegistry
↥Association
Association between endpoint CD2_BENIGN_BRAIN_SUPRATENT and mortality.
Females
| Parameter | HR [95% CI] | p-value |
|---|---|---|
| CD2_BENIGN_BRAIN_SUPRATENT | 1.794 [1.53, 2.1] | < 0.001 |
| Birth year | 1.003 [1.0, 1.01] | 0.441 |
During the follow-up period (1.1.1998 — 31.12.2019), 355 out of 1970 females with CD2_BENIGN_BRAIN_SUPRATENT died.
Males
| Parameter | HR [95% CI] | p-value |
|---|---|---|
| CD2_BENIGN_BRAIN_SUPRATENT | 2.162 [1.81, 2.59] | < 0.001 |
| Birth year | 0.992 [0.98, 1.0] | 0.09 |
During the follow-up period (1.1.1998 — 31.12.2019), 363 out of 1653 males with CD2_BENIGN_BRAIN_SUPRATENT died.
Mortality risk
Mortality risk for people of age
years, who have CD2_BENIGN_BRAIN_SUPRATENT.| N-year risk | Females | Males |
|---|---|---|
| 1 | 0.206% | 0.378% |
| 5 | 1.309% | 2.719% |
| 10 | 2.936% | 7.058% |
| 15 | 5.921% | 13.53% |
| 20 | 11.166% | 22.667% |
Relationships between endpoints
↥Index endpoint: CD2_BENIGN_BRAIN_SUPRATENT – Benign neoplasm: Brain, supratentorial
GWS hits: -
Endpoint
Case Overlap
Survival Analysis
Genetic Correlations
Genetic Signals
N (Jaccard index)
HR [CI]
rg [CI]
Hits
Coloc Hits
FinRegistry
FinnGen
FinRegistry
FinnGen
FinnGen
Loading data